LV12825B - Process for making hiv protease inhibitors - Google Patents

Process for making hiv protease inhibitors

Info

Publication number
LV12825B
LV12825B LVP-02-39A LV020039A LV12825B LV 12825 B LV12825 B LV 12825B LV 020039 A LV020039 A LV 020039A LV 12825 B LV12825 B LV 12825B
Authority
LV
Latvia
Prior art keywords
hiv protease
protease inhibitors
amide
making hiv
hiv
Prior art date
Application number
LVP-02-39A
Other languages
English (en)
Latvian (lv)
Other versions
LV12825A (en
Inventor
David Asikn
Ralph P. VOLANTE
Kan K. Eng
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/187,664 external-priority patent/US5463067A/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of LV12825A publication Critical patent/LV12825A/en
Publication of LV12825B publication Critical patent/LV12825B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-02-39A 1993-07-16 2002-03-15 Process for making hiv protease inhibitors LV12825B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9322593A 1993-07-16 1993-07-16
US08/187,664 US5463067A (en) 1993-07-16 1994-01-26 Process for making HIV protease inhibitors

Publications (2)

Publication Number Publication Date
LV12825A LV12825A (en) 2002-05-20
LV12825B true LV12825B (en) 2002-09-20

Family

ID=26787287

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-02-39A LV12825B (en) 1993-07-16 2002-03-15 Process for making hiv protease inhibitors

Country Status (22)

Country Link
US (2) US5491238A (fr)
EP (1) EP0708762B1 (fr)
JP (1) JP3547136B2 (fr)
CN (2) CN1066723C (fr)
AT (1) ATE200079T1 (fr)
AU (1) AU676079B2 (fr)
CZ (1) CZ293953B6 (fr)
DE (1) DE69426979T2 (fr)
DK (1) DK0708762T3 (fr)
ES (1) ES2155091T3 (fr)
FI (1) FI119473B (fr)
GR (1) GR3035645T3 (fr)
HU (1) HUT74583A (fr)
IL (1) IL110342A (fr)
LV (1) LV12825B (fr)
NO (1) NO306297B1 (fr)
NZ (1) NZ269904A (fr)
PL (1) PL179039B1 (fr)
PT (1) PT708762E (fr)
RU (1) RU2125561C1 (fr)
SK (1) SK282616B6 (fr)
WO (1) WO1995002584A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110255A (en) * 1993-07-16 1998-12-06 Merck & Co Inc Creation and resolution of 2 tert-butylcarboxamidopiprazine
IL111584A0 (en) * 1993-11-18 1995-01-24 Merck & Co Inc Prodrugs of an inhibitor of hiv protease and pharmaceutical compositions containing them
DK0710652T3 (da) * 1994-11-04 1998-09-28 Yamakawa Chemical Ind Fremgangsmåde til fremstilling af optisk aktive piperazinderivater og mellemprodukter til fremstillingen
DE4446025A1 (de) * 1994-12-22 1996-06-27 Basf Ag 2-Caroxamido-1,4,5,6-tetrahydropyrazine
PT744401E (pt) * 1995-05-23 2002-05-31 Lonza Ag Processo para a producao de derivados de acido 2-piperazinocarboxilico opticamente activos
EP1125930A1 (fr) * 1995-05-23 2001-08-22 Lonza Ag Dérivés d'acide 2-pipérazine carboxylique optiquement actifs et procédé de leur préparation
CA2201218C (fr) * 1996-04-23 2004-09-28 Rudolf Fuchs Methode pour la preparation de derives de l'acide piperazine-2-carboxylique optiquement actifs
US6645961B1 (en) 1997-03-07 2003-11-11 Merck & Co., Inc. Dry granulation formulation for an HIV protease inhibitor
US6482952B2 (en) 2000-06-20 2002-11-19 Merck & Co., Inc. Process for preparing acetonides
US7218837B2 (en) 2000-09-25 2007-05-15 Victor Company Of Japan, Ltd. Program-signal recording and reproducing apparatus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2052907A1 (fr) * 1990-10-11 1992-04-12 Joseph P. Vacca Inhibiteurs de la protease du vih a structure symetrique
CA2072237A1 (fr) * 1991-07-02 1993-01-03 Merck & Co., Inc. Production stereoselective de composes hydroxyamide obtenus a partir d'–-aminoepoxydes chiraux
US5169952A (en) * 1991-07-02 1992-12-08 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral α-amino epoxides

Also Published As

Publication number Publication date
GR3035645T3 (en) 2001-06-29
HUT74583A (en) 1997-01-28
EP0708762A1 (fr) 1996-05-01
FI960184A (fi) 1996-03-14
IL110342A0 (en) 1994-10-21
US5496948A (en) 1996-03-05
HU9600077D0 (en) 1996-03-28
PL179039B1 (pl) 2000-07-31
LV12825A (en) 2002-05-20
WO1995002584A2 (fr) 1995-01-26
CN1130380A (zh) 1996-09-04
AU7358894A (en) 1995-02-13
ES2155091T3 (es) 2001-05-01
US5491238A (en) 1996-02-13
NO960168D0 (no) 1996-01-15
CN1192014C (zh) 2005-03-09
CZ293953B6 (cs) 2004-08-18
CZ13196A3 (en) 1996-04-17
AU676079B2 (en) 1997-02-27
NZ269904A (en) 1997-11-24
NO306297B1 (no) 1999-10-18
PL312613A1 (en) 1996-04-29
FI960184A0 (fi) 1996-01-15
RU2125561C1 (ru) 1999-01-27
JPH08509985A (ja) 1996-10-22
ATE200079T1 (de) 2001-04-15
FI119473B (fi) 2008-11-28
CN1066723C (zh) 2001-06-06
JP3547136B2 (ja) 2004-07-28
EP0708762B1 (fr) 2001-03-28
SK282616B6 (sk) 2002-10-08
DE69426979T2 (de) 2001-09-20
DE69426979D1 (de) 2001-05-03
PT708762E (pt) 2001-07-31
DK0708762T3 (da) 2001-04-30
SK5596A3 (en) 1997-01-08
WO1995002584A3 (fr) 1995-03-09
IL110342A (en) 1998-12-27
CN1252402A (zh) 2000-05-10
NO960168L (no) 1996-03-15

Similar Documents

Publication Publication Date Title
NZ326132A (en) Retroviral protease inhibiting compounds
CA2146373A1 (fr) Procede d'obtention de la desacetyl-10 baccatine iii
LV12825B (en) Process for making hiv protease inhibitors
AU3515497A (en) Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid
HUT70205A (en) 1h-indole-3-acetic acid hydrazide spla2 inhibitors, pharmaceutical compositions comprising them and process for producing thereof
AU8133687A (en) Pyrolidineamide derivative having anti-prolyl endopeptidase
HU9602412D0 (en) Process for making an epoxide
MY116862A (en) New processes for preparing pesticidal intermediates
MY107287A (en) A process for the removal of alcohols by distillation.
AU8069801A (en) Stereoselective reduction of substituted oxo-butanes
TW339326B (en) Process for the prepration of lactams
DK0619305T3 (da) Lactonforbindelse og fremgangsmåde til fremstilling deraf
ZA945194B (en) Process for making HIV protease inhibitors
EP0366041A3 (fr) Acides imido-percarboxyliques
AU1083395A (en) Method for making intermediates useful in synthesis of retroviral protease inhibitors
IT1309601B1 (it) Processo per la preparazione di 1,4,7,10 tetraazaciclododecano.
TW336230B (en) Process for the production of olefinic unsaturated compounds
BG102911A (en) Method for cyclosporin purification
MX9700331A (es) Proceso mejorado para r(+)1,2,3,6-tetrahidro-4-fenil-1-[(3-fenil-3-ciclohexen-1-il)metil]pirid ina, un agente del sistema nervioso central.
TW200611691A (en) Retroviral protease inhibiting compounds
MD944G2 (ro) Procedeu de obţinere a amidelor acidului 3,3-diarilacrilic
TW349947B (en) Process for preparing an HIV protease inhibitor